TRANSITIONAL APPOINTMENT OF EXECUTIVE DIRECTOR Melbourne, Australia – 31 August 2026: Percheron Therapeutics Limited (ASX: PER) (‘the Company’), an international biotechnology company focused on developing novel therapies for oncology and rare diseases, is pleased to announce the...